Stock 6550 POLARIS GROUP
Add to a list
To use this feature you must be a member
Log inSign up

Financials Polaris Group

Equities

6550

KYG7171A1085

Biotechnology & Medical Research

End-of-day quote Taiwan S.E.
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
73.3 TWD -0.41% Intraday chart for Polaris Group +2.52% -3.04%
May. 15 Polaris Group Voluntarily Withdraws the Phase III Clinical Trial Protocol for Liver Cancer from the FDA CI
May. 14 Polaris Group Announces Change of the Member of Compensation Committee CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 14,968 8,616 12,275 11,197 48,245 65,793
Enterprise Value (EV) 1 15,382 9,305 9,941 9,669 42,690 58,795
P/E ratio -15.5 x -7.91 x -7.63 x -17 x -67.7 x -56.5 x
Yield - - - - - -
Capitalization / Revenue - - - 1,189,931,875 x 3,207,560,164 x 10,217,874,951 x
EV / Revenue - - - 1,027,567,156 x 2,838,252,273 x 9,131,045,630 x
EV / EBITDA -21.1 x -10.3 x -14.5 x -17.1 x -71.4 x -56.2 x
EV / FCF -44.2 x -25 x -22.3 x -25 x -54.4 x -137 x
FCF Yield -2.26% -3.99% -4.49% -4.01% -1.84% -0.73%
Price to Book 16 x 13.5 x 3.4 x 3.89 x 7.34 x 7.59 x
Nbr of stocks (in thousands) 246,631 285,756 652,901 652,901 654,612 741,746
Reference price 2 60.69 30.15 18.80 17.15 73.70 88.70
Announcement Date 4/30/18 4/22/19 4/20/20 4/19/21 3/3/22 5/26/23
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales - - - 9.41 15.04 6.439
EBITDA 1 -730 -903.2 -687.4 -564.7 -598 -1,046
EBIT 1 -843.7 -1,014 -795.2 -678.1 -731.9 -1,158
Operating Margin - - - -7,205.72% -4,866.15% -17,977.12%
Earnings before Tax (EBT) 1 -897.4 -1,032 -828.9 -660.2 -739.7 -1,145
Net income 1 -898.5 -1,032 -829.8 -660.2 -740.5 -1,150
Net margin - - - -7,016.2% -4,923.12% -17,866.64%
EPS 2 -3.922 -3.811 -2.464 -1.011 -1.089 -1.570
Free Cash Flow 1 -347.7 -371.5 -445.9 -387.3 -784.7 -428.4
FCF margin - - - -4,116.06% -5,216.78% -6,653.27%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/30/18 4/22/19 4/20/20 4/19/21 3/3/22 5/26/23
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q2
Net sales 1 1.768
EBITDA -
EBIT 1 -278
Operating Margin -15,726.02%
Earnings before Tax (EBT) -
Net income -
Net margin -
EPS -
Dividend per Share -
Announcement Date 8/22/22
1TWD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 414 690 - - - -
Net Cash position 1 - - 2,333 1,528 5,555 6,998
Leverage (Debt/EBITDA) -0.5669 x -0.7638 x - - - -
Free Cash Flow 1 -348 -372 -446 -387 -785 -428
ROE (net income / shareholders' equity) -147% -125% -39% -20.3% -14.7% -14.5%
ROA (Net income/ Total Assets) -25.2% -30.2% -16.3% -11.3% -8.18% -8.49%
Assets 1 3,571 3,420 5,077 5,818 9,052 13,549
Book Value Per Share 2 3.800 2.240 5.530 4.410 10.00 11.70
Cash Flow per Share 2 2.230 1.370 4.000 0.2300 8.180 9.740
Capex 1 20.6 43.2 50.2 51 204 69.6
Capex / Sales - - - 542.44% 1,358.57% 1,081.43%
Announcement Date 4/30/18 4/22/19 4/20/20 4/19/21 3/3/22 5/26/23
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
POLARIS GROUP Stock Polaris Group
-3.04% 1.68B
MODERNA, INC. Stock Moderna, Inc.
+49.41% 57.87B
LONZA GROUP AG Stock Lonza Group AG
+41.65% 40.25B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-6.72% 39.94B
CELLTRION, INC. Stock Celltrion, Inc.
-5.96% 28.54B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+12.99% 26.4B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-19.82% 19.33B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+32.35% 12.4B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-0.08% 12.23B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.18% 12.2B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 6550 Stock
  4. Financials Polaris Group